The Valley Desk

NCT00083525 · Interventional trial

Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies

Overall registry status Completed

Phase 1

Conditions Advanced Malignancies

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov